ArticleAlcohol, clinical & experimental research2026
Sex and individual differences in ketamine's effects on alcohol drinking in rats.
Article in Alcohol, clinical & experimental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundEffective pharmacotherapies for Alcohol Use Disorder (AUD) are lacking, and factors such as sex, drinking patterns, and timing of treatment during the addiction cycle may influence treatment efficacy. Clinical studies suggest that ketamine may be effective in AUD; however, preclinical findings have been inconclusive, likely due to varying rodent strains, intake protocols, and ketamine doses/routes. This study investigated ketamine's effects on alcohol drinking in male and female Long Evans rats using multiple validated paradigms.
methodsIn Experiments 1 and 2, rats underwent 4 weeks of intermittent access two-bottle choice (IA2BC) drinking. In Week 5, they received ketamine via intravenous infusion (0.0, 1.47, or 2.35 mg/kg) or intraperitoneal injection (0.0, 10, or 20 mg/kg) during acute withdrawal. Alcohol intake was monitored 24 h posttreatment and for 3 weeks to assess sustained effects. In Experiment 3, rats completed a modified drinking-in-the-dark (DID) protocol for 2 weeks, followed by 2 weeks of forced abstinence. A single ketamine injection preceded re-exposure to alcohol. In Experiment 4, rats were categorized as high or low drinkers after five DID/abstinence cycles. During Cycle 6, six ketamine injections were administered. A final cycle assessed sustained effects.
resultsIn Experiments 1-3, ketamine had no significant acute or lasting effects on alcohol intake in either sex when given during acute withdrawal or following a single period of forced abstinence. In Experiment 4, moderate drinkers (low drinking females, high drinking males) showed reduced intake after the first postabstinence ketamine dose, but not to subsequent dosing. High drinking females responded to both initial and repeated treatments; however, effects did not persist after treatment cessation.
conclusionsKetamine's ability to reduce alcohol intake appears sex-dependent, acute rather than sustained, and limited to high-drinking females. These findings highlight the need to assess the safety of repeated or chronic ketamine use in AUD treatment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.